• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢匹罗对选定的具有β-内酰胺酶介导耐药性的临床肠杆菌分离株的体外活性。

In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.

作者信息

Tzouvelekis L S, Tzelepi E, Mentis A F, Legakis N J

机构信息

Dept. of Bacteriology, Hellenic Pasteur Institute, Athens, Greece.

出版信息

Infection. 1995 Nov-Dec;23(6):384-7. doi: 10.1007/BF01713572.

DOI:10.1007/BF01713572
PMID:8655212
Abstract

Previous studies have shown that there is a high incidence of resistance to cephalosporins among enterobacteria isolated in Greek hospitals. This resistance is mainly due to either the derepression of chromosomal cephalosporinases or the acquisition of plasmids coding for SHV-5 type beta-lactamase. In the present study the activity of cefpirome against a number of enterobacteria (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Enterobacter aerogenes and Serratia marcescens) possessing the mechanisms mentioned above was examined. Cefpirome was found active against all the strains characterized by stable derepression of chromosomal class-C enzymes. The antibiotic was less potent against strains expressing SHV-5 type beta-lactamase due to its hydrolysis by the enzyme. Also cefpirome exhibited good activity against E. aerogenes strains with reduced susceptibility to imipenem. These in vitro data suggest that cefpirome might be useful in treating infections caused by these resistant microorganisms that are frequently encountered in Greek hospitals.

摘要

以往的研究表明,在希腊医院分离出的肠杆菌中,对头孢菌素耐药的发生率很高。这种耐药性主要是由于染色体头孢菌素酶的去阻遏作用,或者是获得了编码SHV-5型β-内酰胺酶的质粒。在本研究中,检测了头孢匹罗对一些具有上述机制的肠杆菌(大肠杆菌、肺炎克雷伯菌、阴沟肠杆菌、产气肠杆菌和粘质沙雷氏菌)的活性。发现头孢匹罗对所有以染色体C类酶稳定去阻遏为特征的菌株均有活性。由于该抗生素被SHV-5型β-内酰胺酶水解,因此对表达该酶的菌株效力较低。此外,头孢匹罗对亚胺培南敏感性降低的产气肠杆菌菌株也表现出良好的活性。这些体外数据表明,头孢匹罗可能有助于治疗希腊医院中经常遇到的由这些耐药微生物引起的感染。

相似文献

1
In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.头孢匹罗对选定的具有β-内酰胺酶介导耐药性的临床肠杆菌分离株的体外活性。
Infection. 1995 Nov-Dec;23(6):384-7. doi: 10.1007/BF01713572.
2
In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.头孢匹罗对β-内酰胺酶诱导型和稳定去阻遏型肠杆菌科细菌的体外活性。
Chemotherapy. 1994 Sep-Oct;40(5):311-6. doi: 10.1159/000239212.
3
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.对第三代头孢菌素耐药的革兰氏阴性杆菌:β-内酰胺酶特性及对Sch 34343的敏感性
J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.
4
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.头孢匹罗(HR 810)是一种对葡萄球菌、肠杆菌科细菌和铜绿假单胞菌有效的吡啶头孢菌素类药物,其体外活性及对β-内酰胺酶的稳定性。
Infection. 1985 May-Jun;13(3):146-55. doi: 10.1007/BF01642876.
5
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].[肠杆菌科细菌对β-内酰胺酶抗生素的耐药机制]
Acta Med Croatica. 2004;58(4):307-12.
6
In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
Chemotherapy. 1996 Sep-Oct;42(5):324-8. doi: 10.1159/000239462.
7
[Development of Beta-lactamase resistance in enterobacteria].[肠道杆菌中β-内酰胺酶耐药性的发展]
Klin Mikrobiol Infekc Lek. 2006 Jun;12(3):103-7.
8
Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.比阿培南对产β-内酰胺酶介导抗生素耐药性肠杆菌的体外比较活性
J Antimicrob Chemother. 1994 Mar;33(3):453-64. doi: 10.1093/jac/33.3.453.
9
[Study of in vitro activity of 3 cephalosporins and their combination with 2 beta-lactamase inhibitors against 4 enterobacteria strains producing extended spectrum beta-lactamase].3种头孢菌素及其与2种β-内酰胺酶抑制剂联合对4株产超广谱β-内酰胺酶肠杆菌的体外活性研究
Pathol Biol (Paris). 1997 May;45(5):425-9.
10
Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.头孢匹罗(HR810)对具有明确β-内酰胺类抗生素耐药机制的铜绿假单胞菌菌株的活性。
J Antimicrob Chemother. 1988 Dec;22(6):841-8. doi: 10.1093/jac/22.6.841.

引用本文的文献

1
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.头孢吡肟、哌拉西林-他唑巴坦与产超广谱β-内酰胺酶肠杆菌科细菌检测中的接种物效应
Antimicrob Agents Chemother. 2001 Dec;45(12):3548-54. doi: 10.1128/AAC.45.12.3548-3554.2001.
2
Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.希腊医院中对头孢吡肟和头孢匹罗耐药的肺炎克雷伯菌菌株的散发性出现。
J Clin Microbiol. 1998 Jan;36(1):266-8. doi: 10.1128/JCM.36.1.266-268.1998.
3
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.

本文引用的文献

1
The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.新的第四代头孢菌素头孢匹罗与其他药物相比的抗菌活性及β-内酰胺酶稳定性。
J Antimicrob Chemother. 1993 May;31(5):699-709. doi: 10.1093/jac/31.5.699.
2
Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.从肺炎克雷伯菌中鉴定出一种具有染色体头孢菌素酶特性的新型质粒介导的β-内酰胺酶。
J Antimicrob Chemother. 1993 May;31(5):645-54. doi: 10.1093/jac/31.5.645.
3
On the incidence of antibiotic resistance among aerobic gram-negative rods isolated in Greek hospitals.
头孢匹罗。关于其抗菌活性、药代动力学特性及治疗严重医院感染和发热性中性粒细胞减少症临床疗效的综述。
Drugs. 1997 Jul;54(1):117-40. doi: 10.2165/00003495-199754010-00013.
希腊医院分离出的需氧革兰氏阴性杆菌中抗生素耐药性的发生率
J Hosp Infect. 1993 Jul;24(3):233-7. doi: 10.1016/0195-6701(93)90052-2.
4
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.导致产气肠杆菌临床菌株体内亚胺培南耐药性出现的连续突变。
J Med Microbiol. 1994 Jun;40(6):403-7. doi: 10.1099/00222615-40-6-403.
5
Bactericidal activity of cefpirome (HR 810) against 513 gram-negative bacteria isolated from blood of septicemic patients.头孢匹罗(HR 810)对从败血症患者血液中分离出的513株革兰氏阴性菌的杀菌活性。
Infection. 1994 Jul-Aug;22(4):299-305. doi: 10.1007/BF01739925.
6
In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.头孢匹罗对β-内酰胺酶诱导型和稳定去阻遏型肠杆菌科细菌的体外活性。
Chemotherapy. 1994 Sep-Oct;40(5):311-6. doi: 10.1159/000239212.
7
Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.希腊医院中产生质粒介导的SHV型β-内酰胺酶的耐头孢菌素粘质沙雷氏菌菌株的传播
Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):764-7. doi: 10.1007/BF02276063.
8
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.来自两项多中心研究的头孢匹罗对头孢他啶耐药菌株的体外抗菌活性。
Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):675-9. doi: 10.1007/BF01973999.
9
Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae.在肺炎克雷伯菌中发现的质粒介导的头孢菌素酶基因(blaLAT-1)的核苷酸序列。
Antimicrob Agents Chemother. 1994 Sep;38(9):2207-9. doi: 10.1128/AAC.38.9.2207.
10
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.头孢匹罗(HR 810)是一种对葡萄球菌、肠杆菌科细菌和铜绿假单胞菌有效的吡啶头孢菌素类药物,其体外活性及对β-内酰胺酶的稳定性。
Infection. 1985 May-Jun;13(3):146-55. doi: 10.1007/BF01642876.